Register for an IASLC STARS Webinar on October 30!

The IASLC STARS (Supportive Training for Advocates on Research and Science) webinar will include a sampling of patient advocate research abstracts presented at the 2023 IASLC World Conference on Lung Cancer (WCLC23) in Singapore. A live Q&A session will follow, moderated by lung cancer patient and research advocate Janet Freeman-Daily. The speakers are Mentors for the 2023 IASLC STARS program:

• Upal Basu Roy, PhD, MPH, Executive Director of Research at LUNGevity Foundation
• Andrew Ciupek, PhD, Associate Director of Clinical Research at GO2 for Lung Cancer
• Jill Feldman, MS, lung cancer patient and research advocate
• Anne-Marie Baird, PhD, president of Lung Cancer Europe (LuCE)
• Lillian Leigh, JD, lung cancer patient and policy advocate

Educational Objectives:

  1. Highlight range of research conducted by lung cancer research advocates and advocacy organizations. 
  2. Demonstrate effective communication of research topics to a broad audience. 
  3. Increase patient research advocates’ understanding of research abstract format and content presented at conferences.
  4. Raise awareness of research advocates contributions to improving patient care and outcomes. 

Live interpretation will be offered in these languages:

  • Chinese (Mandarin)
  • French
  • German
  • Greek
  • Japanese
  • Spanish (Latin America/neutral)

The webinar will be recorded and available for viewing afterwards in each offered language.

Please reach out to advocacy@iaslc.org with any questions.

REGISTER HERE!
https://www.iaslc.org/meetings-webinars/wclc23-you-presented-lung-cancer-research-advocates

A lung cancer care conundrum

I’ve just personally encountered a new-to-me health disparity in the lung cancer space. I’m not aware of tools in the healthcare system that can deal with it.

Lung cancer care was confusing and overwhelming for me when I was diagnosed at age 55–and I was willing and able to access my digital medical records, Google standards of care, and connect with online patient groups. Dealing with my medical appointments and side effects took over my family’s life during my first-line treatment. At least I had an available driver who could accommodate clinic visits that ran long, or could reschedule transport on short notice when radiation therapy was cancelled due to equipment glitches.

The average age for a lung cancer diagnosis is around 70. This means many people are more than 80 years old when diagnosed. How does someone who is legally blind from macular degeneration, hard of hearing, and in an assisted living facility navigate lung cancer care when they can’t read information in online portals, or readily follow verbal conversations with healthcare providers? How can they decide which treatment option will best meet their quality of life goals without reviewing accurate information?

If they don’t have a driver at their beck and call and can’t see to use smartphone or computer apps, how do they get to the array of medical appointments with different providers when they must rely on transportation systems for people with disabilities, which require users to schedule pickups at specific times, days in advance?

Asking for a friend.